30
Investor Presentation October 2016 ASX: BDA For personal use only

For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Embed Size (px)

Citation preview

Page 1: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Investor Presentation October 2016

ASX: BDA

For

per

sona

l use

onl

y

Page 2: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Investment Summary

Focused on delivering natural, Australian made, evidence based

solutions for the body – Inside & Out

Brands positioned across skin care, baby skin care, brain health,

superfoods, antioxidants & immune support segments

Develops, manufactures, markets, imports & exports products

across Australia & Asia

Led by ex-Bellamy’s Organic sales executives

IPO raised $6m at a pre-money valuation of $3.2m

2

For

per

sona

l use

onl

y

Page 3: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Capital Structure & Use of Funds

Indicative IPO capital structure Shares %

Shares Bod Australia 10,000,000 21.7%

Pre-IPO convertible 6,032,000 13.1%

IPO shares (A$6m @ $0.20) 30,000,000 65.2%

Total 46,032,000 100.0%

Issue price $0.20

Market capitalisation $9,206,400

Pre-money valuation $3,206,400

Raised $6m through an Initial Public Offering (IPO)

Funds will be used for marketing, expansion of the sales team, launching new skin & natural

remedies in line with the company’s ‘Inside & Out’ strategy, acquisition of like minded brands &

the expansion into new regions such as China

Approximately 7m options issued as part of IPO

Use of funds Amount ($m)

Marketing 1.5

Investment in stock expansion 1.0

New product development 0.4

Working capital 2.3

Debt repayment 0.15

Expenses of offer 0.65

Total 6.0

3

For

per

sona

l use

onl

y

Page 4: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Key Management

JO PATTERSON – CEO

A strategic marketing & business executive & winner of key awards with more than 20 years’ experience including international exposure

Demonstrated business acumen evidenced by success of own start-up as well as driving established organisations towards growth

Winner – Sydney Business Review Business Woman of Year

Finalist – Telstra Business Woman of Year

Multiple CEO & Managing Director roles over her career

CRAIG WELLER – COO

20 years in the nutritional & pharmaceutical sectors working in general management, senior sales & marketing roles

Five years in evidence based natural medicines – particular focus on mainstream medical market

Extensive Asian experience with Greenfield roles for China, Korea, Indonesia & other countries in Southeast Asia

JOHN GILDER – Head of Sales

Sales manager for Bellamy’s Organic for eight years, overseeing rapid expansion

27 years experience in FMCG & pharmacy sales

Oversaw hugely successful expansion into Chinese market

18 years of sales management experience spread over numerous organisations

4

For

per

sona

l use

onl

y

Page 5: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Industry Overview

Bod is focused on natural skincare products while pursuing

additional verticals in complementary medicines & natural health

1 WHO Traditional Medicine Strategy – 2014-2023 2 2014 Complementary Medicines Industry Survey 3 2014 Complementary Medicines Industry Survey 4 Nicholas Hall’s OTC Insight Asia-Pacific – April 2016

SKIN CARE IN AUSTRALIA Euromonitor International June 2016

SKIN CARE IN AUSTRALIA Euromonitor International June 2016

IRI-Aztec MAT 27/3/16

OTHER VERTICALS

In the last decade there has been a significant increase in

self-health care globally, as consumers choose to be more

proactive about their health1

Revenue of complementary medicines & natural health

products reached $3.5 billion in Australia during 2014 –

expected to grow to $4.6 billion in 2017-20182

Baby care & natural health generate highest sales in

pharmacies outside of products regulated under the PBS

The OTC market across vitamins, minerals & supplements

turned over more than US$11 billion in 2015 across China,

Japan, South Korea & Australia alone

SKIN CARE

The Australian skin care market

achieved sales of almost $1.85

billion in 2015

Small, premium brands rapidly

gaining market share

Pharmacy remains the largest

channel to market with 26% of

all sales, closely followed by

grocery & department stores

82% of the skin care market is

comprised of facial treatments

5

For

per

sona

l use

onl

y

Page 6: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Skin Care Market Outlook

Niche brands expected to continue to gain momentum as consumers

become particular about the beauty & personal care products they

consume

Consumers are more willing to pay a premium on products if they are

seen as effective

Consumers actively follow social media & are strongly influenced by

celebrities & user reviews

Demand for natural skin care will continue as consumers take greater

notice of chemicals in the products they consume

These trends will benefit manufacturers with a natural/organic

positioning & a sustainable approach to beauty & personal care

SKIN CARE IN AUSTRALIA Euromonitor International June 2016

6

For

per

sona

l use

onl

y

Page 7: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Bod Australia Overview

Baby skincare

Bacopa Monnieri (natural remedy)

Natural remedies

for treatment of menopause

Natural remedy

for sinusitis

EXISTING IN DEVELOPMENT

7

For

per

sona

l use

onl

y

Page 8: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Market Positioning

Bod’s positioning is to offer the consumer ‘real’ natural remedies & solutions for Inside & Out. Skincare, natural supplements & remedies

A whole health positioning with a focus on evidence based natural solutions

A number of companies claim a ‘natural positioning’, none couple this with evidence based & clinically trialed products

Reinforced by Bod’s continued investment in research

The positioning for Inside & Out allows a larger platform of solutions to be brought to market

Bod’s positioning will ensure customer loyalty across a wide portfolio of solutions

8

For

per

sona

l use

onl

y

Page 9: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Minimum ingredients. Maximum results.

Unique & effective 30 year old family formula

Natural & active ingredients, evidence based & Australian made

16+ different products with more to be released in 2017

Product range includes anti-ageing, face, exfoliators, baby care, body, cleanse tone & lips

No parabens, BPA’s or other harsh chemicals

Channels to market - Department stores inc 20+ David Jones stores - Pharmacy - Online - Speciality retailers

Gross margin - Department stores – 45% - Pharmacies – 54%

9

For

per

sona

l use

onl

y

Page 10: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

10

For

per

sona

l use

onl

y

Page 11: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Clinical Results

11

For

per

sona

l use

onl

y

Page 12: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

BIOEFFECT

BIOEFFECT is a premium, innovative skin care brand born in Iceland

Based on ten years research & developed by bio-scientists it offers a unique efficacy & purity

The world’s first skincare brand to contain cellular activators made from plants

Results clinically proven in independent clinical trials

Launch professional range Q4 2016 for the professional spa market, adding another 7 new stock keeping units (SKU’s) to the range

Channels to market - Department stores inc 9 David Jones stores - Online - Speciality retailers - Professional spa market

Gross margin - Sephora – 30% - Department stores – 45%

12

For

per

sona

l use

onl

y

Page 13: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

BIOEFFECT

13

For

per

sona

l use

onl

y

Page 14: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Own brand –

Baby Skincare

Developing an all natural, gentle, clinically trialed baby

skincare solution using Australian olive butter & bush

flowers

Launching with 6+ SKU’s covering body wash, nappy rash,

massage serum, shampoo, conditioner & creams

Significant resources allocated for research &

development of this new range

Expected channels to market include department stores,

pharmacies, online & specialty retailers

55% gross margin

Launching 2017

14

For

per

sona

l use

onl

y

Page 15: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Own brand -

Natural remedy – Bacopa Monnieri

Developing a natural remedy for memory & improved concentration based on the extract Bacopa Monnieri

The extract offers enhanced concentration in times of particularly stressful situations such as exams

The active ingredient, an aruvedic herb, has significant data to support the products efficacy & indications

The product is being formulated & manufactured in Australia

Launching in Q2 2017 with 1 SKU

Targeting pharmacy & online channels to market

70% gross margin (pharmacy)

Bacopa Monnieri

Standardised Extract

Finished product

manufactured in Australia

15

For

per

sona

l use

onl

y

Page 16: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Distribution Strategy

Leveraging existing relationships of ex Bellamy’s sales team

Focus on ‘direct to store’ pharmacy distribution in effort to establish a foothold & gain credibility

Currently selling products direct to store via department stores, pharmacies & the professional spa market

Highly efficient sales team across the eastern seaboard of Australia

The sales team operates with tablet technology to activate & process orders that can be uploaded to the financial systems in real time, allowing delivery in 48 hours

Expanding Dr Roebuck’s ‘Everyday Range’ through pharmacies with an expectation of 700 doors by June 2017

22%

26%

19%

5%

14%

6%

8%

Grocery Pharmacy Department Stores Mass Merch Direct Selling Internet Health & Beauty

16

For

per

sona

l use

onl

y

Page 17: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

International Growth Strategy

Dedicated business unit to exploit offshore growth opportunities

Strong demand for all-natural, evidence based products throughout Asia,

especially China

Leveraging strategic relationships to expedite market penetration across

numerous channels:

Direct relationship with retailers

Daigou channel

Online

17

For

per

sona

l use

onl

y

Page 18: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Market Comparables

18

FY16 FY16 FY17 FY17 FY17

Company Code Market Cap

($m) EV ($m) Revenue

($m) EBITDA

($m) F-Revenue

($m) F-EBITDA

($m) EV/EBITDA

BWX Limited BWX $ 406.7 $ 411.1 $ 54.0 $ 20.2 $ 75.4 $ 27.1 15.2

Bellamys Limited BAL $ 1,232.4 $ 1,199.9 $ 244.6 $ 54.6 $ 354.8 $ 78.8 15.2

Vitaco Holdings Limited1 VIT $ 285.2 $ 321.7 $ 257.3 $ 25.6 12.6

McPherson's Limited1 MCP $ 109.8 $ 202.7 $ 312.6 $ 25.7 7.9

Medlab Limited MDC $ 73.3 $ 68.3 $ 2.6 ($ 3.7)

Average 12.7

Median 13.9

Source: Bloomberg and Iress 14 Sept 2016

1. VIT and MCP is trailing FY16 EV/EBITDA as no forecast available on Bloomberg

For

per

sona

l use

onl

y

Page 19: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Board

JO PATTERSON CEO

A strategic marketing & business executive & winner of key awards with more than 20 years’ experience including international exposure

Demonstrated business acumen evidenced by success of own start-up as well as driving established organisations towards growth

Winner – Sydney Business Review Business Woman of Year

Finalist – Telstra Business Woman of Year

Multiple CEO & Managing Director roles over her career

SIMON O’LOUGHLIN

CHAIRMAN

Founder of O’Loughlins Lawyers, an Adelaide based, specialist commercial law firm

He has extensive experience in the corporate & commercial law fields while practising in Sydney & Adelaide, & also holds accounting qualifications

Extensive experience & involvement with companies in the small industrial & resources sectors

He has also been involved in the listing & back-door listing of numerous companies on the ASX, most recently the back-door listings of The Food Revolution Group Limited (formerly Crest Minerals Limited) & Xref Limited (formerly King Solomon Mines Limited)

He is a former Chairman of the Taxation Institute of Australia (SA Division) & Save the Children Fund (SA Division)

SIMON TAYLOR

NON EXECUTIVE DIRECTOR

Simon is a resource executive with over 25 years’ experience in geology, management at CEO & Board levels & in the finance sector

He has had a diversified career as a resources professional providing services to resource companies & financial corporations . This has been at both a technical & corporate level

He has also been involved in the listing & back-door listing of numerous companies on the ASX, most recently the back-door listing of Xref Limited (formerly King Solomon Mines Limited) . Whilst having experience in Australia, a majority of his projects have also been in countries such as Brazil, Turkey, Uganda, Tanzania, Mali, China, the United Kingdom & North America

Mr Taylor is currently an executive director of Oklo Resources Limited & a non-executive director of Chesser Resources Limited & TW Holdings Limited

19

For

per

sona

l use

onl

y

Page 20: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Contact

Management Investor Relations

Jo Patterson Matt Wright

Bod Australia NWR Communications

+61 2 9199 5018 [email protected]

+61 451 896 420

For

per

sona

l use

onl

y

Page 21: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

APPENDICES

21

For

per

sona

l use

onl

y

Page 22: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Australian Skin Care Market Total Sales

(A$ million)

$1,450.0

$1,500.0

$1,550.0

$1,600.0

$1,650.0

$1,700.0

$1,750.0

$1,800.0

$1,850.0

$1,900.0

2010 2011 2012 2013 2014 2015

SKIN CARE IN AUSTRALIA Euromonitor International June 2016 22

For

per

sona

l use

onl

y

Page 23: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Skin Care Category Shares

9%

82%

2%

7%

Body Care Facial Care Hand Care Skin Care Kits

SKIN CARE IN AUSTRALIA Euromonitor International June 2016

The skin care segment in Australia is

skewed towards facial care, which

accounts for more than 80% of the

market

Active ingredients are driving the

market with cosmeceutical brands

gaining traction in Australia

Driven by consumer demand for

functional & advanced products that

include clinically proven ingredients

23

For

per

sona

l use

onl

y

Page 24: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Pharmacy – Other Category’s

Total pharmacy sales outside of those regulated under the PBS have grown

13.3%. The channels of baby care & natural health are two of the channels

that Bod will be targeting for new product development in early 2017.

41.6

32.0

16.0 13.4

11.5 10.4 8.6 8.2 7.6 7.2

0.0

5.0

10.0

15.0

20.0

25.0

30.0

35.0

40.0

45.0

Baby Care NaturalHealth

Skincare Suncare Footcare Oral Care DigestiveCare

Eye & EarCare

Allergy Cough AndCold

IRI-Aztec MAT 27/3/16 24

For

per

sona

l use

onl

y

Page 25: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Baby Skin Care

Baby care is the next largest segment behind infant formula, valued over

$60m in 2016 & growing at 15%

The baby care segment consists of creams, lotions, washes & shampoo.

The fastest growing brands are those offering a natural & healthy

sensitive skin solution for baby

These brands accounted for over 42% of the baby needs category growth

in 2016. Johnson & Johnson now rank number 2, losing share to those

offering a pure & healthy proposition

IRI-Aztec MAT 27/3/16 25

For

per

sona

l use

onl

y

Page 26: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Baby Skin Care

17.3

9

-3.8

0.2

106.2

66.6

15

15.7

-1.4

58.9

-20 0 20 40 60 80 100 120

Infant Formula

Baby Needs

Baby Accessories

Nappies

Baby Food

2016 2015

26

For

per

sona

l use

onl

y

Page 27: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Natural Health Category Many of the segments have displayed double digit growth for the past two

years

The largest segment is nutritional oils followed by multi-vitamins – Swisse

& Blackmores the major players

32.0

92.9

61.9

20.2

-20.0 0.0 20.0 40.0 60.0 80.0 100.0

Total Natural Health

Total Cystitis Relief

Total Brain Health

Total Menopause

2016 2015

IRI-Aztec MAT 27/3/16 27

For

per

sona

l use

onl

y

Page 28: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Brain Health

This segment is currently valued over $12m

& a combined annual growth rate of 25% since 2014

Blackmores, Nature’s Own & Bio Island account for 50%

of the segment sales

DHA Omega 3 & other fish oils are the major products

driving this category & it is a very crowded market

Bod is scheduled to launch a product into this category

in first half of 2017 based on an ancient Ayurvedic herb

which provides improved memory & concentration

Bod is collaborating with Swinburne University on the

clinical data to support the efficacy of this product

IRI-Aztec MAT 27/3/16

28

For

per

sona

l use

onl

y

Page 29: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Women’s Health – Menopause

The segment is valued just under $12m & grew 20% on 2015

Many women want an alternative to hormone replacement

therapy (HRT) when dealing with the biological effects of

menopause (eg. hot flushes)

The growth of this segment has been driven by alternative

therapies that have minimum scientific evidence

Bod believes there is a significant opportunity for a natural

medicine with good clinical evidence to gain market share in

this segment

IRI-Aztec MAT 27/3/16 29

For

per

sona

l use

onl

y

Page 30: For personal use only - ASX · For personal use only. Investment Summary ... for sinusitis EXISTING IN DEVELOPMENT 7 For personal use only. Market Positioning ... portfolio of solutions

Dr Roebuck’s Competitive Analysis DR ROEBUCK'S

(MADE IN AUSTRALIA)

TRILOGY

(MADE IN NZ)

SUKIN

(MADE IN AUSTRALIA)

A'KIN

(MADE IN AUSTRALIA)

PRODUCT

SIZE

(MLS) RRP PRODUCT

SIZE

(MLS) RRP PRODUCT

SIZE

(MLS) RRP PRODUCT

SIZE

(MLS) RRP

EveryDay Rash 50 $15.95 Nil Nil Nil

EveryDay Wax 50 $15.95 Nil Nil Nil

EveryDay Body 150 $19.95 Trilogy Trilogy Ultra

Hydrating Body Cream 150 $25.99

Sukin Hydrating Body

Lotion 250 $12.99

A'kin Unscented

Replenishing Body Moist 200 $26.99

EveryDay Face 50 $29.95 Trilogy Vital

Moisturising Cream 50 $39.99 Sukin Facial Moisturiser 125 $9.99

A'kin Unscented 24 Hour

Pure Moisture 50 $39.99

Cleanse 125 $23.95 Trilogy Cream Cleanser 100 $21.99 Sukin Sensitive Cleansing

Gel 125 $9.99

A'kin Sandalwood &

Neroli Facial Cleansing Gel 225 $27.99

Tone 150 $29.95 Nil Sukin Oil Balancing

Clarifying Facial Tonic 125 $12.99 Nil

Body & Handwash 250 $18.95 Trilogy Botanical Body

Wash 500 24.99 Nil Nil

Wipes 30

wipes $15.95 Nil Nil Nil

Lips 10 $9.95 Trilogy Rosehip Oil Lip

Balm 7 $18.95 Nourishing Lip Treatment 10 $7.10 Nil

30

For

per

sona

l use

onl

y